“Norwegian Biotech Gets U.S. Grant for Bioterrorism Vaccine”

Return to Vaccination News Home Page __» Right-click to "open in new window"

Subscribe to the Vaccination NewsLetter

View past & current Scandals (columns by Sandy Mintz)

Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.

A $2 million grant from the U.S. government will finance the development of bioterrorism vaccines at Inovio, a Norwegian biotechnology company. The vaccines will use Inovio’s gene technology, which injects DNA directly into muscle tissue using electric impulses, rather than having a virus carry the DNA. The result is a faster and longer-lasting vaccine, says Inovio. The company will work on the bioterrorism vaccines in cooperation with the U.S. Army.

Return to Vaccination News Home Page __» Right-click to "open in new window"

DISCLAIMER: All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice. The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.